Allspring Global Investments Holdings LLC reduced its holdings in OSI Systems by 58.1% during the third quarter, disposing of 11,925 shares and ending the period with 8,584 shares. According to its latest 13F filing, the firm’s remaining stake represented roughly 0.05% of the company and was valued at $2.11 million as of the September 30 reporting date. This significant cut follows a period of market volatility in security and inspection technology names, and marks one of the largest single-quarter reductions by a major institutional investor in OSI Systems this year.

Several large funds adjusted their exposure to OSI Systems in the first quarter. Royal Bank of Canada boosted its stake by 519.8%, adding 8,602 shares to reach 10,257 shares valued at $1.99 million. AQR Capital Management increased its position by 64.2%, acquiring 4,558 additional shares for a total of 11,656 shares worth $2.27 million. UBS Asset Management’s distinct business unit made the largest move, snapping up 541,882 shares—a 161.5% increase—culminating in a 877,393‐share position valued at $170.5 million. Combined, hedge funds and institutional investors now hold 89.21% of the company’s outstanding stock.

OSI Systems insiders have been net sellers over the past quarter. Director James B. Hawkins sold 1,500 shares on November 7, generating proceeds of $424,725 and reducing his holdings by 22.95% to 5,036 shares. Chairman Deepak Chopra followed with a sale of 20,000 shares on November 10, raising $5.71 million and trimming his position by 6.39% to 292,969 shares. In total, insiders offloaded 21,916 shares valued at $6.26 million in the last 90 days, bringing insider ownership down to 4.30% of outstanding shares.

Analyst sentiment remains constructive. Roth Capital raised its target from 280.00 to 292.00 and maintained a buy recommendation on December 1. Bank of America issued a buy rating alongside an increase in its objective from 265.00 to 315.00 on November 5. Oppenheimer and UBS Group both lifted their price targets to 280.00 and 292.00, respectively, while JPMorgan Chase & Co. kept a neutral stance but nudged its target up to 255.00. Of the eight analysts covering the stock, seven rate it a buy and one a hold, with a consensus target of 268.63 and full-year EPS guidance set in the range of 10.200 to 10.480.